The diagnostic value of PIVKA-II, AFP, AFP-L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma.
Famei QiAihua ZhouLi YanXiumei YuanDanni WangRuoyun ChangYujun ZhangFuna ShiXiaomei HanJinxia HouLianhua WeiXu ZhangPublished in: Journal of clinical laboratory analysis (2019)
PIVKA-II, AFP-L3, AFP, and CEA are effective biomarkers for the diagnosis of PHC and MHC. Their combinations could improve the diagnostic performance compared with each marker used alone in detecting PHC and MHC.